Connect with us


What’s the Valneva COVID-19 vaccine, the French shot that’s supposed to be ‘variant proof’? – The Conversation AU

It sounds too good to be true, a vaccine that can protect against future virus variants. But governments around the world are keen to learn more.



Article feature image

A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. But it has caught the eye of governments in the UK, Europe and Australia.
One of the vaccines main selling points is its apparent ability to mount a more general immune response against SARS-CoV-2, the virus that causes COVID-19, rather than rely on the spike protein to do this.
This means the vaccine is more likely to be effective against the type of virus variants weve already seen emerging, and may emerge in…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
MicroRNAs in urine could be a promising biomarker to diagnose brain tumors, study reveals –
Article feature image
Scientists urge crackdown on air pollution to help the heart – Advanced Science News